Navigation Links
d’Oliveira & Associates Releases Webpage With Current Information on Fresenius Lawsuits
Date:1/25/2013

(PRWEB) January 25, 2013

NaturaLyte comes as a liquid acid concentrate and dry pack concentrate used in dialysis. According to the New York Times on November 4, 2011, Fresenius issued an internal memo to doctors and dialysis service providers warning that its dialysis products had been linked to an increase in cardiac problems. The memo reported that in the past years 941 patients died from cardiac arrest while using Fresenius products. On March 29, 2012, the Food and Drug Administration (FDA) issued a recall for both GranuFlo and NaturaLyte. The FDA issued the recall after receiving an anonymous copy of the internal memo.

Webpage: Fresenius Lawsuits

Do You Have a Fresenius Claim?

If you believe that you or one of your loved ones have been injured by Fresenius products GranuFlo or NaturaLyte, you may want to speak with a personal injury lawyer regarding a dangerous drug claim. A Fresenius lawyer familiar with new developments in the investigation of the drugs GranuFlo and NaturaLyte may be able to help you make important personal and legal decisions. d'Oliveira & Associates, P.C. is working with some of the leading dangerous drug lawyers and dangerous drug attorneys in the country who are handling these cases.

Please contact the law offices of d'Oliveira & Associates, P.C. at 1-800-992-6878 or fill out a contact form for a free legal consultation.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10334671.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. d’Oliveira & Associates Issues Webpage With Current Information On Stryker Hip Implant Lawsuits
2. Research shows efficacy of treatment model developed at Women & Infants
3. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
4. Vendors in Nevada, Michigan, & Illinois to be Featured on the PartyPOP.com Online Network
5. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
6. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
7. Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case
8. Play & Park Structures Included in New Play for All Abilities Playground
9. Gum Disease, HPV May Play Role in Head & Neck Cancers
10. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines
11. Version 2.0 of Award-Winning Proloquo2Go App for iPhone, iPad & iPod touch Speeds Up Communication, Adds New Voices and Customization Options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... ... Excellence (CoE) with the latest Artificial Intelligence (AI) thinking, announced today the launch ... and easy access to essential information that offers a more comprehensive understanding of ...
(Date:9/20/2017)... ... September 20, 2017 , ... Renal ... for people who have kidney disease. The theme “Describe a positive decision that ... Entrants needed to meet only one qualification— to have been diagnosed with ...
(Date:9/20/2017)... Houston, TX (PRWEB) , ... September 20, 2017 ... ... the date of the much-anticipated fall event , Look Awesome This Autumn ... demonstrations, personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of ... recently unveiled a redesigned website. The new site – still located at ... architects, contractors and other industry users that Garland serves. , After an ambitious ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since going on ... positive feedback from customers trying the product for the first time, and others who ... developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk from multiple ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
(Date:9/1/2017)... Sept. 1, 2017  Bayer will present the latest research ... for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... new preclinical and clinical data on Bayer,s marketed portfolio and ... projects. "We value ... in cancer research at ESMO," said Carsten Brunn , ...
Breaking Medicine Technology: